).
Mohs micrographic surgery (MMS), or Mohs surgery, is a technique used to treat skin malignancies that offers the highest cure rates, maximally spares normal skin, and allows for the best cosmetic and functional results.
1 This technique consists of sequential steps that are performed on the same day in an outpatient setting. In MMS, the Mohs surgeon also functions as the pathologist, thus resulting in better coordination and greater accuracy of clinicopathological correlation. 2 The high cure rates in MMS are achieved through accurate evaluation of 100% of the tissue margins. Thus, the Mohs surgeon's knowledge of dermatopathology and frozen section interpretation is essential to ensure the success of this technique. 3 Mohs micrographic surgery, a tissue-sparing technique, also produces excellent cosmetic and functional results by allowing the surgeon to obtain adequate surgical margins to clear the cancer prior to reconstruction. 4, 5 Of note, the success of MMS relies on tumor contiguity. 6 Noncontiguous or "skip" lesions might not be detected by MMS, thus resulting in higher recurrence rates. 6, 7 Noncontinuity of lesions may occur as a result of previous treatments that failed to completely eradicate the tumor. 6 MMS can also be more cost effective than standard surgical excisions. 8 A recently published review by Tolkachjov et al compared four studies investigating the cost of MMS versus other treatments for skin cancers. 1, [9] [10] [11] [12] Findings showed that MMS and office-based excisions have comparable costs, whereas facility-based excisions or radiotherapy cost more than MMS. 1 The indications for MMS are determined by various features of the skin cancer, the anatomical site involved, and certain patient factors (►Table 1).
3,4,13,14
In recent years, MMS has been increasingly used in the treatment of skin malignancies, 15 which led the Centers for
Medicare & Medicaid Services and insurance companies to impose greater restrictions on this procedure. 1, 15 Thus, an evidence-based criterion was developed jointly by the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. The Mohs Appropriate Use Criteria (AUC) aims to prevent overuse of Mohs surgery, decrease healthcare cost, and achieve optimal clinical results for patients. 14 A smartphone application describing AUC has also been developed to aid dermatologists and Mohs surgeons in their clinical practice.
assistant at the University of Wisconsin, he discovered that injecting 20% zinc chloride solution to tumors caused tissue necrosis but preserved its microscopic architecture. 17, 18 He later formulated and patented a 20% zinc chloride paste that can be applied topically on human skin. 19 He also developed the fixed-tissue technique wherein this paste was applied on the skin cancer in vivo for 24 hours prior to taking the first excision specimen (also referred to as stage or layer). The first layer was then taken the following day, and the specimen was processed using standard paraffin sections. If further stages were necessary, zinc chloride was again applied overnight before the subsequent stage was taken. Thus, it often took several days of surgery and multiple stages to achieve clear margins for large skin cancers.
16,20
In addition, Dr. Mohs introduced the technique of horizontal sectioning and color-coding of specimens, which allowed 100% margin examination while maintaining proper tissue orientation. 
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Although Mohs surgery has developed and advanced in the past few decades, the use of fresh-tissue technique, horizontal tissue sectioning, and total margin control before reconstruction remains the cornerstone of MMS.
Mohs Micrographic Surgery Technique
A signed informed consent is first obtained from the patient after thoroughly discussing the procedure, including its risks, benefits, and alternatives. The site is then identified and marked using a surgical marker (►Fig. 1a). The marked area is shown to the patient to confirm the correct location.
1,3,4
Reviewing photographs and body maps sent by referring physicians to help identify the correct location is important because patients are often unaware or unsure of the previously biopsied site. 28 For referring physicians, it is recommended to mark the lesion and include two anatomical landmarks in the photographs to aid the surgeon in identifying the correct site.
1
Biopsy site selfies may also help patients and physicians identify the correct lesion site.
28
In compliance with the Joint Commission Universal Protocol, a "time-out" is performed to ensure the correct site, patient, and procedure. 29 The site is cleaned with antiseptic solution then infiltrated with local anesthesia. One percent lidocaine with 1:100,000 epinephrine is the most frequently used anesthesia. Buffering with sodium bicarbonate in a 1:10 ratio lessens the pain by increasing the pH of the anesthetic. Slow infiltration of the anesthetic also reduces the pain of injection. 30, 31 Prior to the procedure, the site is again cleaned with antiseptic solution such as chlorhexidine or povidoneiodine. A debulk is performed on the clinically visible tumor either with a curette or a scalpel 1,3,4 (►Fig. 1b). Curetting helps to delineate subclinical margins and potentially lessen the number of Mohs stages. 4, 32 A sharp debulk with a scalpel is preferred for larger or deeper lesions 18 and for lesions that need to be sent for permanent section pathology. For melanoma, for example, the debulk specimen is sent for permanent sections for final staging purposes to evaluate for deeper invasion. 33 Tissue may also be sent to evaluate for lymphovascular or perineural invasion. Tumor debulking also aids in flattening the first Mohs layer for tissue processing to allow adequate visualization of the entire deep and peripheral tissue margins. After debulking the clinically visible tumor, a disc-shaped excision specimen is removed with approximately 1-to 2-mm margins around and underneath the tumor. This removal step is referred to as "taking stages." To obtain the "stage" or "layer," the skin is scored lightly around the specimen using a scalpel (►Fig. 1c). Superficial nicks, also referred to as "hash marks," extending from the specimen to the surrounding skin are then placed at the edges for orientation purposes, for example, at the 3, 6, 9, and 12 o'clock positions (►Fig. 1d). Additional nicks may need to be placed for larger lesions. When removing the specimen, the blade is positioned at a beveled angle (often 45 degrees) (►Fig. 1e), which allows for the tissue edges to be flattened on a single plane for the tissue processing. Once the edges are freed, the deeper tissue may be released with a scalpel or curved iris scissors. The specimen is placed with proper orientation on a piece of blotting paper (►Fig. 1f), and then electrocautery is performed for hemostasis (►Fig. 1g). A pressure bandage is applied, and the patient waits for the specimen to be processed.
1,3,4,13,18
The excised specimen is subsequently inked with different colors within each of the nicks (►Fig. 2a). A map representing the specimen is drawn, and colors of the nicks are indicated using symbols (►Fig. 2b). Consistency in inking and mapping is recommended to increase accuracy and avoid errors. After inking, the specimen is flattened so that all deep and peripheral margins are within the same plane. Sometimes, relaxing cuts within the specimen facilitate this flattening, or for larger pieces, the specimen is cut and inked into multiple pieces. The tissue is then processed using frozen section by a histotechnician. After freezing and embedding, the specimen is sectioned horizontally and mounted on glass slides. The slides are then stained with hematoxylin and eosin dye or toluidine blue. Special stains may be used to help identify certain types of skin cancers.
After processing, the Mohs surgeon examines the slides under the microscope for residual skin cancer.
1,3,4,18
If the Mohs surgeon sees any cancer cells on the microscopic sections (►Fig. 3a), the corresponding area is usually colored with red ink on the Mohs map (►Fig. 3b) to mark out where residual tumor remains. The patient is reanesthezied with local anesthesia, the area is prepped, and the surgeon uses this Mohs map to guide the second "stage" or "layer." An approximately 1-to 2-mm margin of skin or subcutaneous tissue is again taken from the area where cancer cells were identified (►Fig. 3c). The nicks and map are used as reference to clearly delineate the area where cancer is present so that the additional excised specimen will only be taken from the area where remaining cancer cells were seen, preserving as much normal skin as possible. After taking the stage, the specimen is again inked and drawn on the map as previously described. Frozen section processing and staining are performed, and the Mohs surgeon again examines the second stage under the microscope. If skin cancer cells still remain, additional stages are taken until all the margins are clear of cancer cells. When clear margins are achieved, repair options are discussed with the patient.
A recent article by Lee et al used the "peanut butter cup" metaphor to illustrate the concept of MMS. 34 The intact peanut butter cup in its wrapper is compared with the initial specimen obtained during Mohs staging, whereas the wrapper is used to represent the peripheral and deep tissue margins that we evaluate under the microscope. The presence of chocolate or peanut butter signifies residual tumor, which necessitates taking an additional stage from the area where these are visualized. On the other hand, the absence of any chocolate or peanut butter indicates that the margins are clear of cancer.
34
For most cases treated with MMS, the repair or reconstruction is also performed under local anesthesia by the Mohs surgeon on the same day. Preservation of function and cosmesis are important considerations in choosing the repair method. 4 Mohs surgeons are also trained in performing various types of repairs such as primary closures, various 
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skin flaps, and skin grafts. 
Basal Cell Carcinoma
Basal cell carcinomas are the most common types of skin malignancies, and incidence continues to increase annually. 39, 40 Generally, BCCs grow slowly and cause local tissue destruction, but metastasis is very rare. 38 For low-risk cases or patients who are not good surgical candidates, several treatment modalities such as topical chemotherapy agents, photodynamic therapy, electrodessication and curettage, or cryotherapy may be fair options. 6, 37, 40 Radiotherapy and chemotherapy may be considered for patients with large unresectable lesions.
37,38
A meta-analysis conducted by Rowe et al reported a 5-year cure rate of 99% for MMS and 90 to 92% for standard treatments for primary BCC. 40 The same authors also reported that the 5-year cure rate is 94.4% with MMS and 80% with standard treatment for recurrent BCC. 41 A retrospective study conducted by Smeets et al found a 3.2% recurrence rate for primary BCC and 6.7% for recurrent BCC. Risk factors for recurrence include aggressive histological subtype, more than four Mohs stages, large size, and recurrence. MMS is therefore indicated for lesions with higher risk of recurrence.
39
A randomized controlled trial performed by van Loo et al showed a 10-year recurrence of 4.4% for MMS and 12.2% for standard excision in primary BCC. The study also reported a 10-year recurrence rate of 3.9% for MMS and 13.5% for standard excision in recurrent BCC. 42 
Squamous Cell Carcinoma
Cutaneous SCCs are less common than BCCs, but they have a greater potential for recurrence and nodal and organ metastasis. 38 Cure rates have been reported to be higher for MMS compared with WLE.
1
Mohs micrographic surgery is the treatment of choice for high-risk lesions on the lips, ears, nail unit, and penis, and those arising on scars or chronic wounds. 37, 38, [43] [44] [45] [46] It is also ideal for the preservation of functionally important structures. 44, 45 The incidence of SCC is particularly increased among immunosuppressed patients, and these cancers also tend to behave more aggressively. 47 For these patients, MMS offers superior margin control and thus less chance of recurrence, as well as sparing of uninvolved skin and thus better cosmetic and functional results.
47-49

Mohs Micrographic Surgery for Melanoma
Mohs micrographic surgery is recommended by the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and American Society for Mohs Surgery as the treatment of choice for primary and locally recurrent melanoma in situ (MIS) and lentigo maligna on the head and neck, genitalia, acral sites, and the pretibial leg.
14 No specific recommendations has been made for invasive melanoma. Due to the difficulty in identifying melanocytes in frozen sections, several stains have been used to aid in microscopic visualization of melanomas and increase accuracy of histological interpretation. Some of these stains are S-100, HMB-45, Mel-5, MART-1 (also known as Melan-A), MITF, and SOX-10.
50,51 Among these stains, studies have reported a low recurrence of in situ and invasive melanoma with MMS using MART-1 stain. 52 Research has also shown that MART-1 stain is highly sensitive, reliable, and easy to interpret. 33, 52 However, processing of specimen using this stain is usually timeconsuming, and efforts are being made to develop protocols with shorter processing times. [53] [54] [55] Another challenge faced by Mohs surgeons in interpreting histological sections is distinguishing melanoma from background photodamage.
56
Studies have revealed that current guidelines on excision margins for melanoma are inadequate, and wider margins are necessary to ensure complete cancer clearance. report on the use of MMS for the treatment of phaeohyphomycosis of the hand has also been published.
70
Atypical Fibroxanthoma
Atypical fibroxanthoma is a rare spindle cell tumor frequently seen on the head and neck of elderly patients with sun-damaged skin. 60 These tumors may recur and be locally invasive, but metastasis is rare. 60 More aggressive lesions with deeper invasion that have greater potential for recurrence or metastasis are now known as undifferentiated pleomorphic sarcoma (UPS). 71 Some authors proposed that AFX and UPS belong to a disease spectrum, but recent studies show that UPS possesses cytogenetic characteristics and Ras pathway mutations not seen in AFX.
72
A possible reason for recurrence is inadequate surgical margins; thus, MMS is ideal for these patients by allowing 100% margin control prior to reconstruction. 60 Treatment with standard surgical excisions has been found to have high local recurrence rates of approximately 30%.
64
MMSs have also been reported to result in lower recurrence and metastatic rates compared with standard surgical excision. 64, 91 Therefore, MMS is recommended in these patients because of its superior cure rate and maximal tissue conservation, especially around the periocular area.
7,64,91,92
Conclusion
Mohs micrographic surgery is a cost-effective technique for treating skin malignancies and offers the highest cure rates for NMSCs, MIS, and some less common skin malignancies. This can be attributed to its ability to evaluate 100% of the tissue margins through the use of fresh frozen tissue technique, horizontal sectioning, mapping, and color-coding for precise tissue orientation. This technique also allows the conservation of normal tissue while ensuring that the entire cancer has been excised, thus producing the best cosmetic and functional results.
